Anthony G. Viscogliosi

Anthony G. Viscogliosi has twenty-three years of experience as an accomplished founder, entrepreneur, CEO, board member, leading Wall Street analyst, author, visionary and lecturer. He was the first Wall Street orthopedic industry analyst and has authored more than 6,000 pages of investment research on orthopedics. He was also the first Wall Street Orthopedic Investment Banker and has executed more than 170 orthopedic deals of every type as principal or agent, buyer and seller.

Mr. Viscogliosi is a founder of Small Bone Innovations, Inc., where he currently serves as Chairman and Chief Executive Officer. He raised $42.2 million for Small Bone Innovations, Inc. – the single largest round of venture capital financing in orthopedic history at that time. Small Bone Innovations, Inc. was recognized by Red Herring Magazine as one of the Top 100 Companies in North America – the only orthopedic company in the Top 100. Mr. Viscogliosi co-founded Viscogliosi Bros., LLC, the leading merchant bank and venture capital firm focused on the musculoskeletal/orthopedics industry, in 1999. Mr. Viscogliosi is a founder of the leading multi product spine non-fusion private company, Paradigm Spine, LLC. Mr. Viscogliosi is also a founder of the leading Spine Arthroplasty company, Spine Solutions, Inc.; financial founder of the leading Nucleus Arthroplasty company RayMedica, Inc.; founder of the leading reprocessor of single use disposable devices in the USA, Ascent Healthcare Solutions, Inc.; board member of SpineNext in its sale to Abbott; co-founder of a full service Brokerage Firm and Investment Bank, Viscogliosi & Company, Inc.; a co-founder of the leading orthopedic clinical, regulatory, IP and Reimbursement Consulting firm, Musculoskeletal Clinical & Regulatory Advisers, LLC; a founder and Partner in 6 orthopedic focused venture capital & private equity funds, as well as the only orthopedic focused hedge fund. In addition, he is a founder of the NYU-HJD Viscogliosi Bros. Spine Center.

Mr. Viscogliosi received his B.S. in Economics from the University of Michigan in 1984. Prior to co-founding Viscogliosi Bros., he served with several regional brokerage and investment banking firms, as a Senior Vice President and Director of Medical Technology, Co-Director of Research, Assistant Director of Research and as an Equity Research Analyst.

Mr. Viscogliosi was direct-commissioned as an officer in the U.S. Navy Reserve in 1990 during Operation Desert Shield, and is currently a Lieutenant Commander of the United States Navy Reserve. He served on-board the aircraft carrier USS Theodore Roosevelt CVN-71 during the NATO/Bosnia war in 1995, and has served in the Middle East, including Jordan and Bahrain. He was also in Korea during the beginning of the Iraq war, and served as Assistant Officer-In-Charge and Supply Corp Officer for the U.S. Navy Ceremonial Guard which serves the President, Vice President, Joint Chiefs of Staff and Secretary of the Navy.

Mr. Viscogliosi is involved in numerous academic, charitable and philanthropic activities as well. He formerly served as a board member for the Hospital for Joint Diseases and is currently a member of the New York University-HJD Advisory Board. He also serves on the Editorial Council for MX Magazine; Vice-Chairman on the Board of Directors for Junior Achievement of New York; Co-Chairman of the Junior Achievement Endowment Campaign; Co-Chairman of The Chancellor’s Campaign Council at the University of Michigan – Dearborn; Member of The University of Michigan Tri-State Gifts Committee and Henry Ford Estate Advisory Board; Founder and Sponsor of The University of Michigan – Dearborn Viscogliosi Leadership Seminar Series, and is a member of The Woodrow Wilson Council.

John J. Viscogliosi

A talented, driven and experienced strategist and tactician in investing, building and leading musculoskeletal companies with interim CFO, intellectual property managment, ISO 9001 and CE Mark experience. Prior to co-founding Viscogliosi Brothers, LLC in 1999, Mr. Viscogliosi was employed for seven years by several regional brokerage and investment banking firms. Mr. Viscogliosi has broad capital markets experience in institutional and retail sales, institutional listed trading, back office functions and money management. Mr. Viscogliosi has been a Vice President of Investments at Stifel, Nicolaus & Co., Inc., an Associate Director of Investments at Rodman & Renshaw, an Account Executive at First of Michigan Corp. and Dean Witter Reynolds, Inc. and an assistant in the institutional sales and trading department of Martin Simpson & Co., Inc. Mr. Viscogliosi has served on the Board of Directors of three musculoskeletal companies. Mr. Viscogliosi graduated from Wayne State University with a BS in Criminal Justice in 1992.

Marc R. Viscogliosi

A well seasoned leader, manager and clinical and regulatory strategic thinker with six years of investment research, banking and operational experience in musculoskeletal new business development. Prior to co-founding Viscogliosi Brothers, LLC in 1999, Mr. Viscogliosi had spent six years researching and banking musculoskeletal companies. He was employed for four years as a musculoskeletal/orthopedic research associate, primarily working with his brother, Anthony. Mr. Viscogliosi was a research associate at Stifel, Nicolaus & Co., Inc., Rodman & Renshaw, Inc. and Commonwealth Associates. From 1992 to 1993 Mr. Viscogliosi worked as an intern at Martin Simpson & Co. Mr. Viscogliosi has served on two Boards of Directors of musculoskeletal companies. Mr. Viscogliosi graduated from New York University in 1999 with a BA in Economics and Political Science.

David W. Lown
General Manager, MCRA

Mr. David W. Lown has more than 8 years of experience specific to the orthopedic industry and currently serves as General Manager for Musculoskeletal Clinical and Regulatory Advisers, LLC (MCRA). Mr. Lown is responsible for the operational execution and growth of MCRA’s 5 service areas (regulatory, clinical, reimbursement, intellectual property, and quality assurance). Mr. Lown joined the firm in August 2006.

Prior to joining MCRA, Mr. Lown has been employed at Viscogliosi Brothers, LLC (VB), the first and premier merchant banking firm focused on the orthopedic industry. Mr. Lown has worked both for VB’s merchant banking initiatives and as an operating employee within 3 of its portfolio companies. For VB’s merchant banking initiatives, Mr. Lown has worked on the company’s 6 venture funds performing portfolio company investment due diligence, financial and fund analysis, and both US and international deal structuring and transaction execution. Furthermore, Mr. Lown has been responsible in the creation of VB’s 5 most recent company creations: Spine Solutions, Inc. (1999), Paradigm Spine, LLC (2004), Small Bone Innovations, Inc. (2004), and Musculoskeletal Clinical and Regulatory Advisers, LLC (2004) and Surgisoft, LLC (2006). Lastly, Mr. Lown has been responsible for oversight of VB’s principal investments, including Spine Next, SA and Raymedica, Inc.

From an operational standpoint, Mr. Lown’s most recent position has been as Director, Corporate Finance for Small Bone Innovations when he joined the company in August 2004. Mr. Lown was responsible for identifying and structuring mergers and acquisitions, licensing and other corporate-partnering activities, and as such assisted the CEO in the completion of 17 transactions in a two year period. Additionally, Mr. Lown managed a team of upwards of 7 analysts responsible for the company’s financial projections, M&A due diligence, intellectual property, internal analytics, and industry research/competitive intelligence. Mr. Lown also served as a Financial Analyst for Spine Solutions, Inc., the developer of the ProDisc® Lumbar & Cervical total disc technologies that were sold to Synthes, Inc. for $350 million in April 2003.

Mr. Lown graduated from Fordham University with a Bachelor of Science degree in Finance..

Robert C. Dunne, CFA
Portfolio Manager

Mr. Dunne joined VB in December 2003 as the portfolio manager for Orthopedic Investment Partners, LP, a musculoskeletal-focused hedge fund launched by VB in January 2004. Mr. Dunne brings more than 30 years of Wall Street medical-device specific investing experience as a leading analyst and hedge fund portfolio manager with Martin Simpson & Company and as an analyst with Wasserstein, Perella.